title: Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases.
abstract: The objective of the present study was to evaluate the application potential of CyberKnife for high-risk tumors of the central nervous system and to analyze the effectiveness of CyberKnife in relation to dose recovery and gain division (times). A total of Eighty-one targeted areas from 139 central nervous tumor lesions in 60 patients were treated with I-VI ranged CyberKnife for 1 week. Following CyberKnife treatment, imaging tests revealed a decrease in tumor volume, reduction of central nervous system symptoms and an increase in the life quality of patients. The advantages of CyberKnife include non-invasiveness, individualized treatment, flexibility, high accuracy and rapid treatment. CyberKnife produces slight damage and a favorable therapeutic effect and expands our concepts concerning precise radiotherapy for tumors. It is an indispensable method for personalized tumor treatment.
authors.affiliation: Center for Non-Traumatic Treatment and Diagnosis of Tumors, The People's Liberation Army 107th Hospital, Affiliated Hospital of Bin Zhou Medical College, Shandong 264002, P.R. China.
authors.forename: Xin
authors.initials: X
authors.lastname: Wang
authors.forename: Yuan-Yuan
authors.initials: YY
authors.lastname: Wang
authors.forename: Peng
authors.initials: P
authors.lastname: Jiang
authors.forename: Jian-Jun
authors.initials: JJ
authors.lastname: Ma
authors.forename: Zhen
authors.initials: Z
authors.lastname: Qu
authors.forename: Han-Chen
authors.initials: HC
authors.lastname: Liu
authors.forename: Shan-Shan
authors.initials: SS
authors.lastname: Wang
authors.forename: Yi-Shan
authors.initials: YS
authors.lastname: Wang